CA2287838C - Radionuclide associated with nucleotide polyphosphate as tumor imaging agents - Google Patents

Radionuclide associated with nucleotide polyphosphate as tumor imaging agents Download PDF

Info

Publication number
CA2287838C
CA2287838C CA002287838A CA2287838A CA2287838C CA 2287838 C CA2287838 C CA 2287838C CA 002287838 A CA002287838 A CA 002287838A CA 2287838 A CA2287838 A CA 2287838A CA 2287838 C CA2287838 C CA 2287838C
Authority
CA
Canada
Prior art keywords
moiety
group
agent
radionuclide
targeting molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002287838A
Other languages
English (en)
French (fr)
Other versions
CA2287838A1 (en
Inventor
David R. Elmaleh
John W. Babich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of CA2287838A1 publication Critical patent/CA2287838A1/en
Application granted granted Critical
Publication of CA2287838C publication Critical patent/CA2287838C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
CA002287838A 1997-05-01 1998-04-30 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents Expired - Fee Related CA2287838C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/846,999 1997-05-01
US08/846,999 US6187286B1 (en) 1996-12-27 1997-05-01 Tumor imaging agents, methods and kits
PCT/US1998/008776 WO1998048849A1 (en) 1997-05-01 1998-04-30 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents

Publications (2)

Publication Number Publication Date
CA2287838A1 CA2287838A1 (en) 1998-11-05
CA2287838C true CA2287838C (en) 2007-11-20

Family

ID=25299526

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002287838A Expired - Fee Related CA2287838C (en) 1997-05-01 1998-04-30 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents

Country Status (8)

Country Link
US (1) US6187286B1 (https=)
EP (1) EP0975373B1 (https=)
JP (2) JP2002500639A (https=)
AT (1) ATE287734T1 (https=)
AU (1) AU751889B2 (https=)
CA (1) CA2287838C (https=)
DE (1) DE69828779T2 (https=)
WO (1) WO1998048849A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
IL153218A0 (en) 2000-06-02 2003-07-06 Univ Texas Ethylenedicysteine (ec) -drug conjugates
US7560254B2 (en) 2001-08-29 2009-07-14 Ge Healthcare Bio-Sciences Corp. Allele specific primer extension
US7052839B2 (en) * 2001-08-29 2006-05-30 Amersham Biosciences Corp Terminal-phosphate-labeled nucleotides and methods of use
WO2003020734A2 (en) * 2001-08-29 2003-03-13 Amersham Biosciences Corp Labeled nucleoside polyphosphates
US7256019B2 (en) * 2001-08-29 2007-08-14 Ge Healthcare Bio-Sciences Corp. Terminal phosphate blocked nucleoside polyphosphates
US7223541B2 (en) * 2001-08-29 2007-05-29 Ge Healthcare Bio-Sciences Corp. Terminal-phosphate-labeled nucleotides and methods of use
US7033762B2 (en) 2001-08-29 2006-04-25 Amersham Biosciences Corp Single nucleotide amplification and detection by polymerase
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
US8758723B2 (en) * 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
DE102007036559B4 (de) * 2007-08-03 2015-02-19 Siemens Aktiengesellschaft Verfahren zur Detektion und Lokalisierung eines metabolischen Markers, einschließlich Röntgen-CT-System und Röntgen-Projektions-System zur Durchführung dieses Verfahrens
EP3231804B1 (en) 2008-03-21 2021-03-03 The General Hospital Corporation Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
EP3414338B1 (en) * 2016-02-11 2022-12-21 Qiagen Sciences, LLC Polyphenolic additives in sequencing-by-synthesis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
US4510125A (en) * 1982-12-08 1985-04-09 Mallinckrodt, Inc. Process for making lyophilized radiographic imaging kit
ATE66469T1 (de) * 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US5556982A (en) * 1985-01-14 1996-09-17 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5202451A (en) * 1988-02-17 1993-04-13 Neorx Corporation Anchimeric radiometal chelating compounds
US5602244A (en) * 1988-05-26 1997-02-11 Competitive Technologies, Inc. Polynucleotide phosphorodithioate compounds
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
GB8906708D0 (en) * 1989-03-23 1989-05-10 Foxwell Brian M J Improvements relating to the radiolabelling of proteins
CA2241009A1 (en) * 1995-12-28 1997-07-10 Paul C. Zamecnik Cardiovascular and thrombus imaging agents, methods and kits

Also Published As

Publication number Publication date
WO1998048849A9 (en) 1999-04-22
WO1998048849A1 (en) 1998-11-05
ATE287734T1 (de) 2005-02-15
JP2002500639A (ja) 2002-01-08
US6187286B1 (en) 2001-02-13
CA2287838A1 (en) 1998-11-05
DE69828779T2 (de) 2006-01-05
JP2007297404A (ja) 2007-11-15
DE69828779D1 (de) 2005-03-03
AU7171898A (en) 1998-11-24
AU751889B2 (en) 2002-08-29
EP0975373B1 (en) 2005-01-26
EP0975373A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
JP2007297404A (ja) 腫瘍造影剤としてのヌクレオチドポリリン酸に結合された放射性核種
AU656915B2 (en) Stabilized therapeutic radiopharmaceutical complexes
Li et al. Labeling monoclonal antibodies with 90yttrium-and 111indium-DOTA chelates: a simple and efficient method
JP2007291134A (ja) 心臓血管および血栓の造影剤、方法、およびキット
HUT73665A (en) Bifunctional-chelating agents braked with calcogene atoms, pharmaceutical compositions containing them , and use of these compositions in radio- diagnosis and radiotherapy
AU633597B2 (en) 99m tc(iii) myocardial imaging agents that are effective in humans
WO2005087275A2 (en) Metal radiolabeled pet imaging agents
US4515766A (en) Labeled phosphonic acid compositions for investigations of in vivo deposits of calcium
WO1997024146A9 (en) Cardiovascular and thrombus imaging agents, methods and kits
US5879660A (en) Radiolabeled glucans which bind to leukocytes, sites of infection, inflammation, atherosclerosis, or cancer
JP3812680B2 (ja) 放射性医薬用途のペプチド類およびタンパク質類の安定化
EP0201005A2 (en) 99mTc(III)myocardial imaging agents which are non-reducable in vivo
WO1991004057A1 (en) Stable therapeutic radionuclide compositions and methods for preparation thereof
MXPA99010058A (en) Radionuclide associated with nucleotide polyphosphate as tumor imaging agents
JPH1059990A (ja) 放射性標識ウリジン誘導体およびこれを含む医薬
Kaizuka Development of In Vivo Stable Astatine-211 Labeled Scaffold and Its Application in Cancer Radiotheranostics
AU1495601A (en) Cardiovascular and thrombus imaging agents, methods and kits
Laznickova et al. Labeling of a bifunctional monophosphinic acid DOTA analogue with 111 In: Radiochemical aspects and preclinical results
JPH11505852A (ja) 隔離された画像診断剤
Biomedica et al. The United States Department of Energy
Macklis et al. Metallothionein bioconjugates as delivery vehicles for bismuth-212 alpha particle therapy
Xiang et al. 99mTc-HYNIC-TNF analogs (WH701) derived from phage display peptide libraries for imaging TNF-receptor-positive ovarian carcinoma: preclinical evaluation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160502